Advocacy

Bill could help over a million Arizonans build a more secure future

Four Million Americans, Including Arizonans Signed AARP Petition Calling on the Senate and Congress to Act

Four Million Americans, Including 113,709 Arizonans Signed AARP Petition Calling on the Senate and Congress to Act

Confused by long-term care options and who pays? AARP Arizona has a new video to help families navigate this complex system.

For the second pandemic year in a row, AARP Arizona is hosting a virtual Day at the Legislature for members to hear from state lawmakers and AARP leaders on issues important to older Arizonans.

When Tom Doescher moved from Glendale to Phoenix a few years ago, his new utility provider, Arizona Public Service, presented him with a confusing choice of rate plans. Trying to determine which option was least expensive, he used APS’ own online tool. It was a costly mistake.

In 2016, it became apparent that Arizona Public Service (APS) was planning to be the first utility in the country to impose mandatory “demand rates” on residential electric customers. Demand rate plans include an extra charge that is based upon the highest level of energy demand at the customer’s residence during a specified time period the month of service being billed.

Wednesday November 3, 2021

“AARP Arizona is thrilled the Arizona Corporation Commission adopted our recommendations in the APS rate case order issued today. AARP Arizona has been focused on the issues surrounding the previous rate case, which was issued in 2017. AARP Arizona felt strongly enough during those proceedings to be one of only two groups to refuse to sign on to the settlement agreement. With today’s decision, AARP has been vindicated in our decision, and glad to know that then and now we will always fight for the 50+” Dana Kennedy, State Director for AARP Arizona said.

PHOENIX, Arizona—AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy A. LeaMond issued the following statement reacting to the Build Back Better framework’s failure to lower prescription drug prices. LeaMond said: